Together, the two studies add to a growing body of evidence suggesting that GLP-1 medications may affect biological pathways involved in aging
Neuroimaging and cerebrospinal fluid analyses might give us some clues, but more research is needed to identify the right patient populations for these therapies
However, direct DEXA-based comparisons between the two compounds are needed
Other Potential Benefits A challenge with berberine is its low bioavailability
anyway, a violation of federal law, according to the report, pointing out that many of these unregistered ingredients were explicitly marked for compounding and have the potential to harm many Americans. In light of these findings, the Partnership for Safe Medicines, a collection of nonprofits that focus on counterfeit drugs and patient advocacy , called on compounders of GLP-1 drugs to be more transparent with how and where they source their pharmaceutical ingredients